What obesity drugmakers see next in the market: More pills, easier access and drug combinations
Government
The future of the booming obesity drug market won't hinge on drugs that deliver greater weight loss alone. Top executives from drugmakers big and small told CNBC that the next phase of the space will be defined by a broader range of treatment options and improved access for patients. Those were among the themes that emerged at the annual JPMorgan Healthcare Conference in San Francisco during interviews with top brass from Eli Lilly , Novo Nordisk , Pfizer and other drugmakers. "We really see
din zilele anterioare